Multiple Sclerosis Clinical Trials in Paris
14 recruitingParis, France
Showing 1–14 of 14 trials
Recruiting
Phase 3
Efficacy and Safety of Remibrutinib After Switching From Ocrelizumab in Participants Living With Relapsing Multiple Sclerosis.
Relapsing Multiple Sclerosis
Novartis Pharmaceuticals360 enrolled99 locationsNCT06846281
Recruiting
Phase 2
A Study to Evaluate the Safety, Pharmacokinetics, Pharmacodynamics, and Efficacy of RO7268489 as Add-on Therapy to Ocrelizumab, in Participants With Progressive Forms of Multiple Sclerosis (MS)
Progressive Multiple Sclerosis
Hoffmann-La Roche360 enrolled47 locationsNCT07282574
Recruiting
How to Develop the Highest Possible Leading-edge Interdisciplinary Care Model for People With MS, That Will be Relevant to All Stakeholders and Declinable to Different Local Contexts With the Ultimate Goal of Ensuring the Highest Level of Quality of Care in MS.
Multiple Sclerosis
Assistance Publique - Hôpitaux de Paris57 enrolled1 locationNCT07289724
Recruiting
Not Applicable
Exploring Cortical Remyelination in Children With Multiple Sclerosis
Children With Multiple Sclerosis
Assistance Publique - Hôpitaux de Paris40 enrolled3 locationsNCT05258396
Recruiting
Not Applicable
Study of Neuroinflammation in Multiple Sclerosis by PET-MRI Imaging Using the Radiotracer ([18F]-DPA-714) : a Multicentre Cohort Study (INFLANET)
Multiple Sclerosis
Assistance Publique - Hôpitaux de Paris41 enrolled7 locationsNCT06280742
Recruiting
Phase 3
Efficacy and Safety Study of Frexalimab (SAR441344) in Adults With Nonrelapsing Secondary Progressive Multiple Sclerosis
Multiple Sclerosis
Sanofi900 enrolled338 locationsNCT06141486
Recruiting
Phase 3
RItuximab Versus Ocrelizumab in Relapsing-remitting Multiple Sclerosis.
Multiple Sclerosis
Rennes University Hospital386 enrolled23 locationsNCT05758831
Recruiting
Phase 3
Impact of Annual Versus Biannual Infusions of Ocrelizumab in Patients With Active MS,After 2 Years of Initial Treatment, on Freedom From Radiological Disease Activity at Two Years: a Multicenter Randomized Controlled Non-inferiority Trial
Multiple Sclerosis
Fondation Ophtalmologique Adolphe de Rothschild244 enrolled11 locationsNCT05999604
Recruiting
Detection of Spinal Cord Lesions Using the MP2RAGE Sequence in Inflammatory Diseases of the Neuraxis
Multiple Sclerosis
Fondation Ophtalmologique Adolphe de Rothschild196 enrolled1 locationNCT06589999
Recruiting
Multimodal Imaging Signatures of the Biological Mechanisms Underlying Neurodegeneration in Multiple Sclerosis
Multiple Sclerosis (MS)
Assistance Publique - Hôpitaux de Paris80 enrolled1 locationNCT05633875
Recruiting
Phase 2
TOTEM RRMS : TestOsterone TreatmEnt on Neuroprotection and Myelin Repair in Relapsing Remitting Multiple Sclerosis
Multiple Sclerosis, Relapsing-Remitting
University Hospital, Strasbourg, France40 enrolled5 locationsNCT03910738
Recruiting
Not Applicable
Comparing Transanal Irrigation With Navina Smart vs. Standard Bowel Care in Patients With Multiple Sclerosis
Multiple SclerosisFecal IncontinenceNeurogenic Bowel (Disorder)+1 more
Wellspect HealthCare92 enrolled9 locationsNCT04707976
Recruiting
Serum Neurofilament-light Chain and GFAP Levels in Patients From the OFSEP Cohort at Different Landmarks of Multiple Sclerosis
Multiple Sclerosis
Centre Hospitalier Universitaire de Nīmes1,150 enrolled28 locationsNCT03981003
Recruiting
Phase 3
Disease Modifying Therapies Withdrawal in Inactive Secondary Progressive Multiple Sclerosis Patients Older Than 50 Years (STOP-I-SEP)
Multiple Sclerosis
Rennes University Hospital250 enrolled27 locationsNCT03653273